Greenlight Capital

David Einhorn

Latest filing · Q2 2026

Bought more than soldFiled Aug 14, 2026 for holdings on Jun 30, 2026, 45 days after the quarter ended. The next one is due by Nov 14, 2026.

Stocks reported

$3.91B

as of Jun 30, 2026

Positions

all shown below

Top 10 stocks

52.8%

of the money in stocks

Options

None

none reported

What changed in Q2 2026

compared with Q1 2026, by number of shares

New buys7

FBINFortune Brands Innovations I3.1%
VGNTVersigent2.4%
PRMBPrimo Brands1.8%
PYPLPayPal1.6%
Warner Bros Discovery1.5%
PVHPvh1.0%
CMCSAComcast0.8%

Added to11

SHCSotera Health100% more
CNRCore Natural Resources22.9% more
DCHDauch96.4% more
ARAntero Resources94.7% more
VTRSViatris52.6% more
BKVBkv14.8% more
TRIPTripadvisor51.0% more
HSICHenry Schein19.9% more
and 3 more in the filing

Trimmed11

CNCCentene39.6% fewer
VSNTVersant Media Group36.5% fewer
SNXTd Synnex20.5% fewer
SPBSpectrum Brands13.7% fewer
GLDSPDR Gold Shares16.3% fewer
FLRFluor1.9% fewer
DHTDht Holdings4.5% fewer
PENNPenn Entertainment3.0% fewer
and 3 more in the filing

Exited6

VSXYVictoria's Secretwas 3.3%
SLMSLMwas 1.4%
PTONPeloton Interactivewas 1.4%
WFRDWeatherford International Plwas 0.4%
ZIMZim Integrated Shipping Servwas 0.3%
Katapultwas 0.0%

Portfolio

as of Jun 30, 2026 · source

#	Holding	Weight	Value	Shares	Vs last quarter	Held since
1	GRBKGreen Brick Partners	19.4%	$758M	9.5M	No change	Q4 2014
2	FLRFluor Trimmed −1.9%	6.2%	$244M	4.7M	Trimmed −1.9%	Q2 2025
3	CNRCore Natural Resources Added +22.9%	4.7%	$183M	2.3M	Added +22.9%	Q1 2025
4	BHFBrighthouse Financial	4.6%	$180M	2.8M	No change	Q3 2017
5	ACHCAcadia Healthcare Trimmed −2.6%	3.3%	$130M	4.4M	Trimmed −2.6%	Q4 2024
6	PENNPenn Entertainment Trimmed −3.0%	3.2%	$125M	5.9M	Trimmed −3.0%	Q4 2013
7	FBINFortune Brands Innovations I New	3.1%	$123M	2.2M	New	Q2 2026
8	PCGP G & E	2.9%	$112M	6.6M	No change	Q3 2025
9	CNCCentene Trimmed −39.6%	2.7%	$106M	1.7M	Trimmed −39.6%	Q1 2020
10	GPKGraphic Packaging Added +9.4%	2.7%	$105M	10.0M	Added +9.4%	Q2 2021
11	SNXTd Synnex Trimmed −20.5%	2.6%	$102M	381K	Trimmed −20.5%	Q3 2020
12	Teva Pharmaceutical Inds Trimmed −0.9%	2.5%	$97.8M	2.9M	Trimmed −0.9%	Q4 2023
13	VGNTVersigent New	2.4%	$95.7M	2.3M	New	Q2 2026
14	CPRICapri Trimmed −2.2%	2.3%	$89.5M	4.8M	Trimmed −2.2%	Q1 2021
15	BKVBkv Added +14.8%	2.2%	$84.7M	3.1M	Added +14.8%	Q4 2025
16	DHTDht Holdings Trimmed −4.5%	2.1%	$83.2M	5.0M	Trimmed −4.5%	Q3 2023
17	CROXCrocs	2.1%	$80.7M	669K	No change	Q1 2026
18	ROIVRoivant Sciences	1.9%	$76.2M	2.2M	No change	Q1 2024
19	SHCSotera Health Added +100%	1.9%	$73.4M	4.1M	Added +100%	Q2 2023
20	VSNTVersant Media Group Trimmed −36.5%	1.8%	$69.2M	1.9M	Trimmed −36.5%	Q1 2026

Show 26 more

21	PRMBPrimo Brands New	1.8%	$69.0M	2.8M	New	Q2 2026
22	DCHDauch Added +96.4%	1.7%	$67.2M	12.4M	Added +96.4%	Q1 2026
23	PYPLPayPal New	1.6%	$61.5M	1.4M	New	Q1 2018
24	HSICHenry Schein Added +19.9%	1.5%	$60.0M	719K	Added +19.9%	Q4 2025
25	Warner Bros Discovery New	1.5%	$59.9M	2.2M	New	Q2 2022
26	LBTYALiberty Global	1.4%	$56.4M	5.0M	No change	Q1 2024
27	ARAntero Resources Added +94.7%	1.4%	$55.3M	1.6M	Added +94.7%	Q4 2025
28	STUBStubhub Holdings	1.4%	$54.5M	4.2M	No change	Q1 2026
29	REZIResideo Technologies Added +7.9%	1.4%	$52.9M	1.7M	Added +7.9%	Q2 2020
30	DECKDeckers Outdoor Added +5.2%	1.3%	$50.3M	506K	Added +5.2%	Q4 2025
31	SPBSpectrum Brands Trimmed −13.7%	1.2%	$48.1M	561K	Trimmed −13.7%	Q4 2025
32	CNHCnh Industrial	1.2%	$47.0M	4.2M	No change	Q3 2024
33	VTRSViatris Added +52.6%	1.1%	$44.0M	2.8M	Added +52.6%	Q4 2023
34	SKYDSkydance	1.0%	$38.7M	3.9M	No change	Q1 2026
35	PVHPvh New	1.0%	$38.7M	521K	New	Q1 2016
36	CMCSAComcast New	0.8%	$33.0M	1.3M	New	Q2 2026
37	SLDESlide Insurance	0.8%	$32.7M	1.7M	No change	Q4 2025
38	TRIPTripadvisor Added +51.0%	0.8%	$32.4M	2.4M	Added +51.0%	Q1 2026
39	GLDSPDR Gold Shares Trimmed −16.3%	0.8%	$30.7M	83K	Trimmed −16.3%	Q2 2020
40	CIThe Cigna	0.6%	$24.4M	88K	No change	Q2 2025
41	LKFTLakefront Biotherapeutic	0.4%	$14.5M	483K	No change	Q4 2021
42	COYACoya Therapeutics	0.3%	$13.7M	2.3M	No change	Q4 2022
43	IMVTImmunovant	0.1%	$3.6M	94K	No change	Q1 2026
44	GPROGopro	<0.1%	$1.3M	1.7M	No change	Q1 2021
45	GANXGain Therapeutics	<0.1%	$1.1M	566K	No change	Q1 2021
46	NUVBNuvation Bio	<0.1%	$199K	35K	No change	Q1 2021

Values at quarter end, not today's prices.

Filing history

53 quarters since Q2 2013

Quarter	Filed	Lag	Stocks	Positions	Filing
Q2 2026	Aug 14, 2026	45d	$3.91B	46	EDGAR
Q1 2026	May 15, 2026	45d	$3.19B	45	EDGAR
Q4 2025	Feb 17, 2026	48d	$2.85B	41	EDGAR
Q3 2025	Nov 14, 2025	45d	$2.54B	37	EDGAR
Q2 2025	Aug 14, 2025	45d	$2.33B	34	EDGAR
Q1 2025	May 15, 2025	45d	$1.97B	33	EDGAR
Q4 2024	Feb 14, 2025	45d	$1.94B	36	EDGAR
Q3 2024	Nov 14, 2024	45d	$2.40B	38	EDGAR
Q2 2024	Aug 14, 2024	45d	$2.04B	39	EDGAR
Q1 2024	May 15, 2024	45d	$2.18B	42	EDGAR
Q4 2023	Feb 14, 2024	45d	$2.05B	40	EDGAR
Q3 2023	Nov 14, 2023	45d	$1.76B	39	EDGAR
Q2 2023	Aug 14, 2023	45d	$2.13B	41	EDGAR
Q1 2023	May 15, 2023	45d	$1.84B	39	EDGAR
Q4 2022	Feb 14, 2023	45d	$1.44B	41	EDGAR
Q3 2022	Nov 14, 2022	45d	$1.41B	42	EDGAR
Q2 2022	Aug 15, 2022	46d	$1.29B	47	EDGAR
Q1 2022	May 16, 2022	46d	$1.57B	52	EDGAR
Q4 2021	Feb 14, 2022	45d	$1.64B	56	EDGAR
Q3 2021	Nov 15, 2021	46d	$1.49B	58	EDGAR
Q2 2021	Aug 16, 2021	47d	$1.59B	71	EDGAR
Q1 2021	May 17, 2021	47d	$1.44B	62	EDGAR
Q4 2020	Feb 16, 2021	47d	$1.64B	35	EDGAR
Q3 2020	Nov 16, 2020	47d	$1.21B	35	EDGAR
Q2 2020	Aug 14, 2020	45d	$915M	22	EDGAR
Q1 2020	May 15, 2020	45d	$696M	22	EDGAR
Q4 2019	Feb 14, 2020	45d	$1.35B	18	EDGAR
Q3 2019	Nov 14, 2019	45d	$1.39B	19	EDGAR
Q2 2019	Aug 14, 2019	45d	$1.36B	22	EDGAR
Q1 2019	May 15, 2019	45d	$1.41B	18	EDGAR
Q4 2018	Feb 14, 2019	45d	$1.38B	20	EDGAR
Q3 2018	Nov 14, 2018	45d	$2.37B	20	EDGAR
Q2 2018	Aug 14, 2018	45d	$3.14B	29	EDGAR
Q1 2018	May 15, 2018	45d	$3.99B	35	EDGAR
Q4 2017	Feb 14, 2018	45d	$5.50B	43	EDGAR
Q3 2017	Nov 14, 2017 *	45d	$6.18B	37	EDGAR
Q2 2017	Aug 14, 2017	45d	$6.20B	33	EDGAR
Q1 2017	May 15, 2017	45d	$6.56B	36	EDGAR
Q4 2016	Feb 14, 2017	45d	$4.95B	32	EDGAR
Q3 2016	Nov 14, 2016	45d	$5.23B	36	EDGAR
Q2 2016	Aug 15, 2016	46d	$5.45B	45	EDGAR
Q1 2016	May 16, 2016	46d	$5.90B	42	EDGAR
Q4 2015	Feb 16, 2016	47d	$5.46B	48	EDGAR
Q3 2015	Nov 16, 2015	47d	$5.94B	40	EDGAR
Q2 2015	Aug 14, 2015	45d	$7.97B	41	EDGAR
Q1 2015	May 15, 2015 *	45d	$7.79B	44	EDGAR
Q4 2014	Feb 13, 2015	44d	$7.52B	42	EDGAR
Q3 2014	Nov 14, 2014	45d	$6.93B	47	EDGAR
Q2 2014	Aug 14, 2014	45d	$7.18B	40	EDGAR
Q1 2014	May 15, 2014 *	45d	$6.57B	40	EDGAR
Q4 2013	Feb 14, 2014	45d	$7.29B	38	EDGAR
Q3 2013	Nov 14, 2013 *	45d	$6.03B	31	EDGAR
Q2 2013	Aug 14, 2013	45d	$5.33B	30	EDGAR

They usually file 45 days after the quarter ends. * amended later.

Earlier filings, quarter by quarter

Aug 14
NewFBIN3.1% of the bookNewVGNT2.4% of the bookNewPRMB1.8% of the bookNewPYPL1.6% of the bookAddedSHC100% more sharesAddedCNR22.9% more shares
Holdings as of Jun 30 (Q2 2026), filed 45 days later (the report at the SEC)
May 15
NewVSNT3.5% of the bookNewCROX1.7% of the bookNewREZI1.7% of the bookNewSLM1.4% of the bookAddedSNX749% more sharesAddedPTON4,004% more shares
Holdings as of Mar 31 (Q1 2026), filed 45 days later (the report at the SEC)
Feb 17
NewWarner Bros Discovery Inc1.6% of the bookNewSPB1.4% of the bookNewHSIC1.2% of the bookNewGPN1.2% of the bookAddedGPK78.8% more sharesAddedCPRI77.4% more shares
Holdings as of Dec 31 (Q4 2025), filed 48 days later (the report at the SEC)
Nov 14
NewPCG3.8% of the bookNewPRKS1.0% of the bookNewNXST0.6% of the bookNewKWEB0.1% of the bookAddedFLR44.4% more sharesAddedKD31.2% more shares
Holdings as of Sep 30 (Q3 2025), filed 45 days later (the report at the SEC)
Aug 14
NewFLR8.4% of the bookNewCI1.3% of the bookNewVSXY0.7% of the bookNewSHC0.1% of the bookAddedGPK349% more sharesAddedTeva Pharmaceutical Inds Ltd565% more shares
Holdings as of Jun 30 (Q2 2025), filed 45 days later (the report at the SEC)
May 15
NewCNR8.6% of the bookNewDLTR1.7% of the bookAddedTECK84.0% more sharesAddedCPRI65.4% more sharesAddedHPQ43.0% more sharesAddedSDRL107% more shares
Holdings as of Mar 31 (Q1 2025), filed 45 days later (the report at the SEC)

About Greenlight Capital: Value investor with a concentrated long book. Files as DME Capital Management since 2024. A 13F is up to 45 days old when filed and shows long US stock positions only. Not investment advice.